This is the authors' abstract. We don't add key points for this paper.
This study demonstrates for the first time that MDSCs play a critical role in attenuating acute inflammation in the liver, and that agents such as CBD, which trigger MDSCs through activation of TRPV1 vanilloid receptors may constitute a novel therapeutic modality to treat inflammatory diseases.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hegde et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: